Frontiers in Cardiovascular Medicine (Jun 2024)

Tachyarrhythmias in congenital heart disease

  • Jaume Francisco-Pascual,
  • Jaume Francisco-Pascual,
  • Jaume Francisco-Pascual,
  • Núria Mallofré Vila,
  • Alba Santos-Ortega,
  • Alba Santos-Ortega,
  • Alba Santos-Ortega,
  • Nuria Rivas-Gándara,
  • Nuria Rivas-Gándara,
  • Nuria Rivas-Gándara

DOI
https://doi.org/10.3389/fcvm.2024.1395210
Journal volume & issue
Vol. 11

Abstract

Read online

The prevalence of congenital heart disease (CHD) in adult patients has risen with advances in diagnostic and surgical techniques. Surgical modifications and hemodynamic changes increase the susceptibility to arrhythmias, impacting morbidity and mortality rates, with arrhythmias being the leading cause of hospitalizations and sudden deaths. Patients with CHD commonly experience both supraventricular and ventricular arrhythmias, with each CHD type associated with different arrhythmia patterns. Macroreentrant atrial tachycardias, particularly cavotricuspid isthmus-dependent flutter, are frequently reported. Ventricular arrhythmias, including monomorphic ventricular tachycardia, are prevalent, especially in patients with surgical scars. Pharmacological therapy involves antiarrhythmic and anticoagulant drugs, though data are limited with potential adverse effects. Catheter ablation is preferred, demanding meticulous procedural planning due to anatomical complexity and vascular access challenges. Combining imaging techniques with electroanatomic navigation enhances outcomes. However, risk stratification for sudden death remains challenging due to anatomical variability. This article practically reviews the most common tachyarrhythmias, treatment options, and clinical management strategies for these patients.

Keywords